International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy
Jean‐Baptiste Beuscart(Université de Lille), Anne Spinewine(UCLouvain), Benoît Boland(Cliniques Universitaires Saint-Luc), Denis O’Mahony(University College Cork), Nicolas Rodondi(General Department of Preventive Medicine), Claudio Schneider(University Hospital of Bern), Wilma Knol(Utrecht University), Shane Cullinan(Royal College of Surgeons in Ireland), Stefanie Thevelin(UCLouvain), Paul A. F. Jansen(Utrecht University), Olivia Dalleur(Cliniques Universitaires Saint-Luc)
Cited by 134
Related Papers
STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria
|Age and Ageing|2008|689
Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation
|Circulation|2017|247
Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline
|BMJ|2019|230
Relationships of Overt and Silent Brain Lesions With Cognitive Function in Patients With Atrial Fibrillation
|Journal of the American College of Cardiology|2019|228